Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory Papillomatosis.

Saved in:
Bibliographic Details
Title: Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory Papillomatosis.
Authors: Mau T; Department of Otolaryngology-Head and Neck Surgery, Voice Center, University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A., Amin MR; Department of Otolaryngology-Head and Neck Surgery, New York University Grossman School of Medicine, New York, New York, U.S.A., Belafsky PC; Department of Otolaryngology/Head and Neck Surgery, Davis School of Medicine, University of California, Sacramento, California, U.S.A., Best SR; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A., Friedman AD; Division of Laryngology, Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, U.S.A., Klein AM; Department of Otolaryngology-Head and Neck Surgery, Emory University, Atlanta, Georgia, U.S.A., Lott DG; Division of Laryngology, Mayo Clinic Arizona, Phoenix, Arizona, U.S.A., Paniello RC; Department of Otolaryngology - Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, U.S.A., Pransky SM; Pediatric Specialty Partners of San Diego, San Diego, California, U.S.A., Saba NF; Department of Hematology and Medical Oncology, The Winship Cancer Institute, Emory University, Atlanta, Georgia, U.S.A., Howard T; Inovio Pharmaceuticals, Plymouth Meeting, Plymouth, Pennsylvania, U.S.A., Dallas M; Inovio Pharmaceuticals, Plymouth Meeting, Plymouth, Pennsylvania, U.S.A., Patel A; Inovio Pharmaceuticals, Plymouth Meeting, Plymouth, Pennsylvania, U.S.A., Morrow MP; Inovio Pharmaceuticals, Plymouth Meeting, Plymouth, Pennsylvania, U.S.A., Skolnik JM; Inovio Pharmaceuticals, Plymouth Meeting, Plymouth, Pennsylvania, U.S.A.
Source: The Laryngoscope [Laryngoscope] 2023 Nov; Vol. 133 (11), pp. 3087-3093. Date of Electronic Publication: 2023 May 19.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8607378 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-4995 (Electronic) Linking ISSN: 0023852X NLM ISO Abbreviation: Laryngoscope Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1531-4995
DOI:10.1002/lary.30749